CD274 and gastric cancer: M1-like TAMs are an independent prognostic factor in GC, and CD68+CD163-macrophages, a group of representative M1-like TAMs, can be used as predictive biomarkers to guide PD-1/PD-L1 antibody treatment in GC (28).